All In Biotech

Free tool

FAERS Monitor: Neupogen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103353 or its brand name (Neupogen, Filgrastim). Reports on generic versions are filed under their own applications.

Reports

37,808

Serious

33,318

88% of reports

Hospitalization

17,163

Death reported

8,531

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • febrile neutropenia4,533
  • neutropenia3,559
  • off label use3,198
  • pyrexia2,929
  • diarrhoea2,297
  • death2,288
  • nausea2,067
  • thrombocytopenia2,022
  • pneumonia1,923
  • fatigue1,864
  • anaemia1,832
  • sepsis1,511
  • vomiting1,488
  • white blood cell count decreased1,439
  • pancytopenia1,366

Reports by year received

View as table
YearReports
2004422
2005432
2006483
2007701
2008855
2009826
2010895
20111,381
20121,832
20131,169
20141,372
20151,609
20161,752
20171,717
20182,275
20192,130
20202,517
20213,218
20222,982
20232,710
20242,834
20252,360
20261,333

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,351 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal4,53340.739.6164,154
neutropeniaSignal3,55914.914.545,311
pancytopeniaSignal1,36613.913.216,002
thrombocytopeniaSignal2,02210.29.816,605
sepsisSignal1,5117.67.38,620
white blood cell count decreasedSignal1,4397.57.17,993
anaemiaSignal1,8325.45.16,535
pyrexiaSignal2,9294.74.68,712
pneumoniaSignal1,9233.33.23,142
off label useSignal3,1982.02.01,750
diarrhoea2,2972.01.91,150
vomiting1,4881.81.7500
death2,2881.51.4368
nausea2,0671.51.4303
fatigue1,8641.31.3160

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.